The NBS1–Treacle complex controls ribosomal RNA transcription in response to DNA damage

Abstract: Chromosome breakage elicits transient silencing of ribosomal RNA synthesis, but the mechanisms involved remained elusive.

Abstract: Here we discover an in trans signalling mechanism that triggers pan-nuclear silencing of rRNA transcription in response to DNA damage.

Abstract: This is associated with transient recruitment of the Nijmegen breakage syndrome protein 1 (NBS1), a central regulator of DNA damage responses, into the nucleoli.

Abstract: We further identify TCOF1 (also known as Treacle), a nucleolar factor implicated in ribosome biogenesis and mutated in Treacher Collins syndrome, as an interaction partner of NBS1, and demonstrate that NBS1 translocation and accumulation in the nucleoli is Treacle dependent.

Abstract: Finally, we provide evidence that Treacle-mediated NBS1 recruitment into the nucleoli regulates rRNA silencing in trans in the presence of distant chromosome breaks.


Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts.

Abstract: Activated T cells secrete multiple osteoclastogenic cytokines which play a major role in the bone destruction associated with rheumatoid arthritis.

Abstract: While the role of T cells in osteoclastogenesis has received much attention recently, the effect of T cells on osteoblast formation and activity is poorly defined.

Abstract: In this study, we investigated the hypothesis that in chronic inflammation activated T cells contribute to enhanced bone turnover by promoting osteoblastic differentiation.

Abstract: We show that T cells produce soluble factors that induce alkaline phosphatase activity in bone marrow stromal cells and elevated expression of mRNA for Runx2 and osteocalcin.

Abstract: This data indicate that T cell derived factors have the capacity to stimulate the differentiation of bone marrow stromal cells into the osteoblast phenotype.

Abstract: RANKL mRNA was undetectable under any conditions in highly purified bone marrow stromal cells.

Abstract: In contrast, RANKL was constitutively expressed in primary osteoblasts and only moderately up-regulated by activated T cell conditioned medium.

Abstract: Interestingly, both bone marrow stromal cells and osteoblasts expressed mRNA for RANK, which was strongly up-regulated in both cell types by activated T cell conditioned medium.

Abstract: Although, mRNA for the RANKL decoy receptor, osteoprotegerin, was also up-regulated by activated T cell conditioned medium, it's inhibitory effects may be mitigated by a simultaneous rise in the osteoprotegerin competitor TNF-related apoptosis-inducing ligand.

Abstract: Based on our data we propose that during chronic inflammation, T cells regulate bone loss by a dual mechanism involving both direct stimulation of osteoclastogenesis, by production of osteoclastogenic cytokines, and indirectly by induction of osteoblast differentiation and up-regulation of bone turnover via coupling.


Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group.

Abstract: BACKGROUND Lowering the blood cholesterol level may reduce the risk of coronary heart disease.

Abstract: This double-blind study was designed to determine whether the administration of pravastatin to men with hypercholesterolemia and no history of myocardial infarction reduced the combined incidence of nonfatal myocardial infarction and death from coronary heart disease.

Abstract: METHODS We randomly assigned 6595 men, 45 to 64 years of age, with a mean (+/-

Abstract: SD) plasma cholesterol level of 272 +/-

Abstract: 23 mg per deciliter (7.0 +/- 0.6 mmol per liter) to receive pravastatin (40 mg each evening) or placebo.

Abstract: The average follow-up period was 4.9 years.

Abstract: Medical records, electrocardiographic recordings, and the national death registry were used to determine the clinical end points.

Abstract: RESULTS Pravastatin lowered plasma cholesterol levels by 20 percent and low-density-lipoprotein cholesterol levels by 26 percent, whereas there was no change with placebo.

Abstract: There were 248 definite coronary events (specified as nonfatal myocardial infarction or death from coronary heart disease) in the placebo group, and 174 in the pravastatin group (relative reduction in risk with pravastatin, 31 percent; 95 percent confidence interval, 17 to 43 percent; P < 0.001).

Abstract: There were similar reductions in the risk of definite nonfatal myocardial infarctions (31 percent reduction, P < 0.001), death from coronary heart disease (definite cases alone: 28 percent reduction, P = 0.13; definite plus suspected cases: 33 percent reduction, P = 0.042), and death from all cardiovascular causes (32 percent reduction, P = 0.033).

Abstract: There was no excess of deaths from noncardiovascular causes in the pravastatin group.

Abstract: We observed a 22 percent reduction in the risk of death from any cause in the pravastatin group (95 percent confidence interval, 0 to 40 percent; P = 0.051).

Abstract: CONCLUSIONS Treatment with pravastatin significantly reduced the incidence of myocardial infarction and death from cardiovascular causes without adversely affecting the risk of death from noncardiovascular causes in men with moderate hypercholesterolemia and no history of myocardial infarction.


Validation of a migraine-specific questionnaire for use in family studies.

Abstract: The availability of valid migraine-specific questionnaires is important when large numbers of migraine patients have to be analysed.

Abstract: The Finnish Migraine-Specific Questionnaire has been validated in two stages.

Abstract: In the first, a clinical diagnosis of migraine was reached, using International Headache Society criteria, in 100 consecutive patients.

Abstract: Migraine was then diagnosed independently on the basis of responses to the Finnish Migraine-Specific Questionnaire.

Abstract: In the second stage, responses to 100 questionnaires returned consecutively in a family study in progress were analysed, and respondents were contacted by telephone for interview and diagnosis of migraine.

Abstract: Contact proved impossible in six cases.

Abstract: The sensitivity of the questionnaire for migraine was 0.99 (167 out of 168; validation stages 1 and 2 combined) and specificity was 0.96 (25 out of 26 cases; validation stage 2).

Abstract: It also proved possible to differentiate between migraine with and without aura on the basis of responses to the Finnish Migraine-Specific Questionnaire: chance-corrected agreement (Cohen's kappa) was 0.804 in relation to diagnoses reached on the basis of responses to the Finnish Migraine-Specific Questionnaire and clinically was 0.858 in relation to diagnoses reached on the basis of responses to the Finnish Migraine-Specific Questionnaire combined with the results of the telephone interviews.

Abstract: A value for Cohen's kappa > 0.75 indicates good agreement.

Abstract: Therefore, use of the Finnish Migraine-Specific Questionnaire in research into migraine genetics is justified.


Defining early lineage specification of human embryonic stem cells by the orchestrated balance of canonical Wnt/beta-catenin, Activin/Nodal and BMP signaling.

Abstract: The canonical Wnt/beta-catenin signaling has remarkably diverse roles in embryonic development, stem cell self-renewal and cancer progression.

Abstract: Here, we show that stabilized expression of beta-catenin perturbed human embryonic stem (hES)-cell self-renewal, such that up to 80% of the hES cells developed into the primitive streak (PS)/mesoderm progenitors, reminiscent of early mammalian embryogenesis.

Abstract: The formation of the PS/mesoderm progenitors essentially depended on the cooperative action of beta-catenin together with Activin/Nodal and BMP signaling pathways.

Abstract: Intriguingly, blockade of BMP signaling completely abolished mesoderm generation, and induced a cell fate change towards the anterior PS progenitors.

Abstract: The PI3-kinase/Akt, but not MAPK, signaling pathway had a crucial role in the anterior PS specification, at least in part, by enhancing beta-catenin stability.

Abstract: In addition, Activin/Nodal and Wnt/beta-catenin signaling synergistically induced the generation and specification of the anterior PS/endoderm.

Abstract: Taken together, our findings clearly demonstrate that the orchestrated balance of Activin/Nodal and BMP signaling defines the cell fate of the nascent PS induced by canonical Wnt/beta-catenin signaling in hES cells.


Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate.

Abstract: Consistent with previous reports, sphingosine at a high concentration (5 microM) was cardiotoxic as evidenced by increased infarct size in response to ischemia/reperfusion in an ex vivo rat heart.

Abstract: Sphingosine 1-phosphate (S1P) at 5 microM was cardioprotective.

Abstract: However, at a physiologic concentration (0.4 microM) sphingosine as well as S1P was effective in protecting the heart from ischemia/reperfusion injury both when perfused prior to 40 min of ischemia (preconditioning) or when added to reperfusion media following ischemia (postconditioning).

Abstract: Protection by sphingosine and S1P was evidenced with both pre- and post-conditioning by a >75% recovery of left ventricular developed pressure during reperfusion and a decrease in infarct size from 45% of the risk area to less than 8%.

Abstract: When VPC23019, an S1P(1and3)G-protein coupled receptor antagonist, was added to the preconditioning or postconditioning medium along with S1P, it completely blocked S1P-induced protection.

Abstract: However, VPC 23019 did not affect the ability of 0.4 microM sphingosine to either precondition or postcondition hearts.

Abstract: Studies of preconditioning revealed that inhibition of protein kinase C with GF109203X blocked preconditioning by S1P.

Abstract: However, GF109203X did not affect preconditioning by 0.4 microM sphingosine.

Abstract: Likewise, cotreatment with the PI3 kinase inhibitor wortmanin blocked preconditioning by S1P but not by sphingosine.

Abstract: By contrast, inhibition of protein kinase G with KT5823 had no effect on S1P preconditioning but completely eliminated preconditioning by sphingosine.

Abstract: Also, the protein kinase A inhibitory peptide 14-22 amide blocked preconditioning by sphingosine but not S1P.

Abstract: These data reveal for the first time that sphingosine is not toxic at physiologic concentrations but rather is a potent cardioprotectant that utilizes a completely different mechanism than S1P; one that is independent of G-protein coupled receptors and utilizes cyclic nucleotide-dependent pathways.


Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha.

Abstract: Transcriptional coactivators showing physical and functional interactions with PPARgamma include the protein acetyl transferase p300, the TRAP/Mediator complex that interacts with the general transcription machinery, and the highly regulated PGC-1alpha.

Abstract: We show that PGC-1alpha directly interacts with TRAP/Mediator, through the PPARgamma-interacting subunit TRAP220, and stimulates TRAP/Mediator-dependent function on DNA templates.

Abstract: Further, while ineffective by itself, PGC-1alpha stimulates p300-dependent histone acetylation and transcription on chromatin templates in response to PPARgamma.

Abstract: These functions are mediated by largely independent PPARgamma, p300, and TRAP220 interaction domains in PGC-1alpha, whereas p300 and TRAP220 show ligand-dependent interactions with a common region of PPARgamma.

Abstract: Apart from showing PGC-1alpha functions both in chromatin remodeling and in preinitiation complex formation or function (transcription), these results suggest a key role for PGC-1alpha, through concerted but dynamic interactions, in coordinating these steps.


Phospholipid synthesis and lipid composition of subcellular membranes in the unicellular eukaryote Saccharomyces cerevisiae.

Abstract: Subcellular membranes of Saccharomyces cerevisiae, including mitochondria, microsomes, plasma membranes, secretory vesicles, vacuoles, nuclear membranes, peroxisomes, and lipid particles, were isolated by improved procedures and analyzed for their lipid composition and their capacity to synthesize phospholipids and to catalyze sterol delta 24-methylation.

Abstract: The microsomal fraction is heterogeneous in terms of density and classical microsomal marker proteins and also with respect to the distribution of phospholipid-synthesizing enzymes.

Abstract: The specific activity of phosphatidylserine synthase was highest in a microsomal subfraction which was distinct from heavier microsomes harboring phosphatidylinositol synthase and the phospholipid N-methyltransferases.

Abstract: The exclusive location of phosphatidylserine decarboxylase in mitochondria was confirmed.

Abstract: CDO-diacylglycerol synthase activity was found both in mitochondria and in microsomal membranes.

Abstract: Highest specific activities of glycerol-3-phosphate acyltransferase and sterol delta 24-methyltransferase were observed in the lipid particle fraction.

Abstract: Nuclear and plasma membranes, vacuoles, and peroxisomes contain only marginal activities of the lipid-synthesizing enzymes analyzed.

Abstract: The plasma membrane and secretory vesicles are enriched in ergosterol and in phosphatidylserine.

Abstract: Lipid particles are characterized by their high content of ergosteryl esters.

Abstract: The rigidity of the plasma membrane and of secretory vesicles, determined by measuring fluorescence anisotropy by using trimethylammonium diphenylhexatriene as a probe, can be attributed to the high content of ergosterol.


Use of health services by prison inmates: comparisons with the community.

Abstract: The future organisation of prison health care 1 recommends that the NHS and the Prison Service work together to plan and provide health care services for prisoners.

Abstract: Whereas previously the Prison Service had this responsibility alone.

Abstract: The NHS will therefore have to take stock of the current level at which prison health care is demanded and provided.

Abstract: A key part of the information base for joint planning therefore includes data on current service utilisation.

Abstract: This paper compares primary care and inpatient health service utilisation data for UK prisoners with health services utilisation data for equivalent community populations.

Abstract: In the community, primary care is provided principally by general practitioners and professions allied to medicine (mostly nurses).

Abstract: Residents in the community have access to the full range of NHS outpatient and inpatient facilities.

Abstract: Within prisons, primary care is provided by medical officers (some of whom are general practitioners), nursing grades and health care officers (who have received some training in health care).

Abstract: Some prisons have their own inpatient facilities (health care centre beds).

Abstract: These provide a low level of inpatient care and do not have a direct equivalent in the community.

Abstract: Prisoners also have access to NHS outpatient and inpatient facilities and to visiting specialists.

Abstract: The prison population has a high turnover and varies from day to day.

Abstract: Because of this, the prison population is expressed as an average daily population during a one year period.


Regulation of p53 in response to DNA damage

Abstract: Activation of p53 can occur in response to a number of cellular stresses, including DNA damage, hypoxia and nucleotide deprivation.

Abstract: Several forms of DNA damage have been shown to activate p53, including those generated by ionising radiation (IR), radio-mimetic drugs, ultraviolet light (UV) and chemicals such as methyl methane sulfonate (MMS).

Abstract: Under normal conditions, p53 levels are maintained at a low state by virtue of the extremely short-half life of the polypeptide.

Abstract: In addition to this, p53 normally exists in an largely inactive state that is relatively inefficient at binding to DNA and activating transcription.

Abstract: Activation of p53 in response to DNA damage is associated with a rapid increase in its levels and with an increased ability of p53 to bind DNA and mediate transcriptional activation.

Abstract: This then leads to the activation of a number of genes whose products trigger cell-cycle arrest, apoptosis, or DNA repair.

Abstract: Recent work has suggested that this regulation is brought about largely through DNA damage triggering a series of phosphorylation, de-phosphorylation and acetylation events on the p53 polypeptide.

Abstract: Here, we discuss the nature of these modifications, the enzymes that bring them about, and how changes in p53 modification lead to p53 activation.


Hydrogen sulphide regulates intracellular pH in vascular smooth muscle cells.

Abstract: We investigated the role of hydrogen sulphide (H(2)S) in intracellular pH (pH(i)) regulation in vascular smooth muscle cells and its contribution on vasodilation.

Abstract: NaHS, a H(2)S donor, decreased pH(i) in a concentration-dependent manner ranging from 10 microM to 1mM. Neither inhibition of the Na(+)/H(+) exchanger with 5-(N-ethyl-N-isopropyl) amiloride, (EIPA, 10 microM), nor plasmalemmal Ca(2+)-ATPase with CdCl(2) (20nM) alters the effect of NaHS on pH(i).

Abstract: Blockade of the Cl(-)/HCO3- exchanger with 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid (DIDS) significantly attenuated the pH(i) lowering effect of NaHS.

Abstract: Moreover, NaHS significantly increased the activity of Cl(-)/HCO3- exchanger when measured with NH(4)Cl prepulse method.

Abstract: DIDS attenuated the vasorelaxation induced by NaHS whereas EIPA and CdCl(2) did not cause any change.

Abstract: In conclusion, H(2)S induced intracellular acidification via activation of Cl(-)/HCO3- exchanger, which is, at least partially, responsible for H(2)S-mediated vasorelaxation.


Cell and biomolecule delivery for tissue repair and regeneration in the central nervous system.

Abstract: Tissue engineering frequently involves cells and scaffolds to replace damaged or diseased tissue.

Abstract: It originated, in part, as a means of effecting the delivery of biomolecules such as insulin or neurotrophic factors, given that cells are constitutive producers of such therapeutic agents.

Abstract: Thus cell delivery is intrinsic to tissue engineering.

Abstract: Controlled release of biomolecules is also an important tool for enabling cell delivery since the biomolecules can enable cell engraftment, modulate inflammatory response or otherwise benefit the behavior of the delivered cells.

Abstract: We describe advances in cell and biomolecule delivery for tissue regeneration, with emphasis on the central nervous system (CNS).

Abstract: In the first section, the focus is on encapsulated cell therapy.

Abstract: In the second section, the focus is on biomolecule delivery in polymeric nano/microspheres and hydrogels for the nerve regeneration and endogenous cell stimulation.

Abstract: In the third section, the focus is on combination strategies of neural stem/progenitor cell or mesenchymal stem cell and biomolecule delivery for tissue regeneration and repair.

Abstract: In each section, the challenges and potential solutions associated with delivery to the CNS are highlighted.


The angiotensin II type 1 receptor blocker olmesartan preferentially improves nocturnal hypertension and proteinuria in chronic kidney disease

Abstract: Accumulated evidence suggests that an altered ambulatory blood pressure (BP) profile, particularly elevated nighttime BP, reflects target organ injury and is a better predictor of further cardiorenal risk than the clinic BP or daytime BP in hypertensive patients complicated by chronic kidney disease (CKD).

Abstract: In this study, we examined the beneficial effects of olmesartan, an angiotensin II type 1 receptor blocker (ARB), on ambulatory BP profiles and renal function in hypertensive CKD patients.

Abstract: Forty-six patients were randomly assigned to the olmesartan add-on group (n=23) or the non-ARB group (n=23).

Abstract: At baseline and after the 16-week treatment period, ambulatory BP monitoring was performed and renal function parameter measurements were collected.

Abstract: Although the baseline clinic BP levels and the after-treatment/baseline (A/B) ratios of clinic BP levels were similar in the olmesartan add-on and non-ARB groups, the A/B ratios of ambulatory 24-h and nighttime BP levels in the olmesartan add-on group were significantly lower.

Abstract: Furthermore, the A/B ratios of urinary protein, albumin and type IV collagen excretion in the olmesartan add-on group were significantly lower than those in the non-ARB group (urinary protein excretion, 0.72±0.41 vs. 1.45±1.48, P=0.030; urinary albumin excretion, 0.73±0.37 vs. 1.50±1.37, P=0.005; urinary type IV collagen excretion, 0.87±0.42 vs. 1.48±0.87, P=0.014) despite comparable A/B ratios for the estimated glomerular filtration rate in the two groups.

Abstract: These results indicate that in hypertensive patients with CKD, olmesartan add-on therapy improves the ambulatory BP profile via a preferential reduction in nighttime BP with concomitant renal injury inhibition.


Surgical vs nonsurgical treatment of adults with displaced fractures of the proximal humerus: the PROFHER randomized clinical trial.

Abstract: IMPORTANCE The need for surgery for the majority of patients with displaced proximal humeral fractures is unclear, but its use is increasing.

Abstract: OBJECTIVE To evaluate the clinical effectiveness of surgical vs nonsurgical treatment for adults with displaced fractures of the proximal humerus involving the surgical neck.

Abstract: DESIGN, SETTING, AND PARTICIPANTS A pragmatic, multicenter, parallel-group, randomized clinical trial, the Proximal Fracture of the Humerus Evaluation by Randomization (PROFHER) trial, recruited 250 patients aged 16 years or older (mean age, 66 years [range, 24-92 years]; 192 [77%] were female; and 249 [99.6%] were white) who presented at the orthopedic departments of 32 acute UK National Health Service hospitals between September 2008 and April 2011 within 3 weeks after sustaining a displaced fracture of the proximal humerus involving the surgical neck.

Abstract: Patients were followed up for 2 years (up to April 2013) and 215 had complete follow-up data.

Abstract: The data for 231 patients (114 in surgical group and 117 in nonsurgical group) were included in the primary analysis.

Abstract: INTERVENTIONS Fracture fixation or humeral head replacement were performed by surgeons experienced in these techniques.

Abstract: Nonsurgical treatment was sling immobilization.

Abstract: Standardized outpatient and community-based rehabilitation was provided to both groups.

Abstract: MAIN OUTCOMES AND MEASURES Primary outcome was the Oxford Shoulder Score (range, 0-48; higher scores indicate better outcomes) assessed during a 2-year period, with assessment and data collection at 6, 12, and 24 months.

Abstract: Sample size was based on a minimal clinically important difference of 5 points for the Oxford Shoulder Score.

Abstract: Secondary outcomes were the Short-Form 12 (SF-12), complications, subsequent therapy, and mortality.

Abstract: RESULTS There was no significant mean treatment group difference in the Oxford Shoulder Score averaged over 2 years (39.07 points for the surgical group vs 38.32 points for the nonsurgical group; difference of 0.75 points [95% CI, -1.33 to 2.84 points]; P = .48) or at individual time points.

Abstract: There were also no significant between-group differences over 2 years in the mean SF-12 physical component score (surgical group: 1.77 points higher [95% CI, -0.84 to 4.39 points];

Abstract: P = .18); the mean SF-12 mental component score (surgical group: 1.28 points lower [95% CI, -3.80 to 1.23 points]; P = .32); complications related to surgery or shoulder fracture (30 patients in surgical group vs 23 patients in nonsurgical group; P = .28), requiring secondary surgery to the shoulder (11 patients in both groups), and increased or new shoulder-related therapy (7 patients vs 4 patients, respectively; P = .58); and mortality (9 patients vs 5 patients; P = .27).

Abstract: Ten medical complications (2 cardiovascular events, 2 respiratory events, 2 gastrointestinal events, and 4 others) occurred in the surgical group during the postoperative hospital stay.

Abstract: CONCLUSIONS AND RELEVANCE Among patients with displaced proximal humeral fractures involving the surgical neck, there was no significant difference between surgical treatment compared with nonsurgical treatment in patient-reported clinical outcomes over 2 years following fracture occurrence.

Abstract: These results do not support the trend of increased surgery for patients with displaced fractures of the proximal humerus.

Abstract: TRIAL REGISTRATION isrctn.com Identifier: ISRCTN50850043.


Kinetics and Fidelity of the Repair of Cas9-Induced Double-Strand DNA Breaks

Abstract: The RNA-guided DNA endonuclease Cas9 is a powerful tool for genome editing.

Abstract: Little is known about the kinetics and fidelity of the double-strand break (DSB) repair process that follows a Cas9 cutting event in living cells.

Abstract: Here, we developed a strategy to measure the kinetics of DSB repair for single loci in human cells.

Abstract: Quantitative modeling of repaired DNA in time series after Cas9 activation reveals variable and often slow repair rates, with half-life times up to ∼10 hr.

Abstract: Furthermore, repair of the DSBs tends to be error prone.

Abstract: Both classical and microhomology-mediated end joining pathways contribute to the erroneous repair.

Abstract: Estimation of their individual rate constants indicates that the balance between these two pathways changes over time and can be altered by additional ionizing radiation.

Abstract: Our approach provides quantitative insights into DSB repair kinetics and fidelity in single loci and indicates that Cas9-induced DSBs are repaired in an unusual manner.


Network meta-analysis for indirect treatment comparisons.

Abstract: I present methods for assessing the relative effectiveness of two treatments when they have not been compared directly in a randomized trial but have each been compared to other treatments.

Abstract: These network meta-analysis techniques allow estimation of both heterogeneity in the effect of any given treatment and inconsistency ('incoherence') in the evidence from different pairs of treatments.

Abstract: A simple estimation procedure using linear mixed models is given and used in a meta-analysis of treatments for acute myocardial infarction.


Liver transplantation and opioid dependence.

Abstract: ContextChronic hepatitis C is the leading cause for liver transplantation in the United States.

Abstract: Intravenous drug use, the major risk factor, accounts for approximately 60% of hepatitis C virus transmission.

Abstract: Information from the United Network of Organ Sharing (UNOS) does not address substance use among liver transplantation patients.

Abstract: ObjectiveTo identify addiction-related criteria for admission to the UNOS liver transplantation waiting list and posttransplantation problems experienced by patients who are prescribed maintenance methadone.

Abstract: Design, Setting, and ParticipantsMail survey of all 97 adult US liver transplantation programs (belonging to UNOS) in March 2000 with telephone follow-up conducted in May and June 2000.Main Outcome MeasuresPrograms' acceptance and management of patients with past or present substance use disorder.

Abstract: ResultsOf the 97 programs surveyed, 87 (90%) responded.

Abstract: All accept applicants with a history of alcoholism or other addictions, including heroin dependence.

Abstract: Eighty-eight percent of the responding programs require at least 6 months of abstinence from alcohol; 83% from illicit drugs.

Abstract: Ninety-four percent have addiction treatment requirements.

Abstract: Consultations from substance abuse specialists are obtained by 86%.

Abstract: Patients receiving methadone maintenance are accepted by 56% of the responding programs.

Abstract: Approximately 180 patients receiving methadone maintenance are reported to have undergone liver transplantation.

Abstract: ConclusionsMost liver transplantation programs have established policies for patients with substance use disorders.

Abstract: Opiate-dependent patients receiving opiate replacement therapy seem underrepresented in transplantation programs.

Abstract: Little anecdotal evidence for negative impact of opiate replacement therapy on liver transplantation outcome was found.

Abstract: Policies requiring discontinuation of methadone in 32% of all programs contradict the evidence base for efficacy of long-term replacement therapies and potentially result in relapse of previously stable patients.


RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates.

Abstract: Double-stranded RNA (dsRNA) produced during viral replication is believed to be the critical trigger for activation of antiviral immunity mediated by the RNA helicase enzymes retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5).

Abstract: We showed that influenza A virus infection does not generate dsRNA and that RIG-I is activated by viral genomic single-stranded RNA (ssRNA) bearing 5'-phosphates.

Abstract: This is blocked by the influenza protein nonstructured protein 1 (NS1), which is found in a complex with RIG-I in infected cells.

Abstract: These results identify RIG-I as a ssRNA sensor and potential target of viral immune evasion and suggest that its ability to sense 5'-phosphorylated RNA evolved in the innate immune system as a means of discriminating between self and nonself.


In-hospital switching between adenosine diphosphate receptor inhibitors in patients with acute myocardial infarction treated with percutaneous coronary intervention: Insights into contemporary practice from the TRANSLATE-ACS study.

Abstract: AIMS While randomized clinical trials have compared clopidogrel with higher potency adenosine diphosphate (ADP) receptor inhibitors among patients with acute myocardial infarction, little is known about the frequency, effectiveness and safety of switching between ADP receptor inhibitors in routine clinical practice.

Abstract: METHODS AND RESULTS We studied 11,999 myocardial infarction patients treated with percutaneous coronary intervention at 230 hospitals from April 2010 to October 2012 in the TRANSLATE-ACS study.

Abstract: Multivariable Cox regression was used to compare six-month post-discharge risks of major adverse cardiovascular events (MACE: death, myocardial infarction, stroke, or unplanned revascularization) and Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-defined bleeding between in-hospital ADP receptor inhibitor switching versus continuation of the initially selected therapy.

Abstract: Among 8715 patients treated initially with clopidogrel, 994 (11.4%) were switched to prasugrel or ticagrelor; switching occurred primarily after percutaneous coronary intervention (60.9%) and at the time of hospital discharge (26.7%).

Abstract: Among 3284 patients treated initially with prasugrel or ticagrelor, 448 (13.6%) were switched to clopidogrel; 48.2% of switches occurred after percutaneous coronary intervention and 48.0% at hospital discharge.

Abstract: Switching to prasugrel or ticagrelor was not associated with increased bleeding when compared with continuation on clopidogrel (2.7% vs. 3.3%, adjusted hazard ratio 0.96, 95% confidence interval 0.64-1.42, p=0.82).

Abstract: Switching from prasugrel or ticagrelor to clopidogrel was not associated with increased MACE (8.9% vs. 7.7%, adjusted hazard ratio 1.06, 95% confidence interval 0.75-1.49, p=0.76) when compared with continuation on the higher potency agent.

Abstract: CONCLUSIONS In-hospital ADP receptor inhibitor switching occurs in more than one in 10 myocardial infarction patients in contemporary practice.

Abstract: In this observational study, ADP receptor inhibitor switching does not appear to be significantly associated with increased hazard of MACE or bleeding.


Platelet activation in type 2 diabetes mellitus.

Abstract: The abnormal metabolic state that accompanies diabetes renders arteries susceptible to atherosclerosis, being capable of altering the functional properties of multiple cell types, including endothelium and platelets.

Abstract: In particular, an altered platelet metabolism and changes in intraplatelet signaling pathways may contribute to the pathogenesis of atherothrombotic complications of diabetes.

Abstract: A variety of mechanisms may be responsible for enhanced platelet aggregation.

Abstract: Among them, hyperglycemia may represent a causal factor for in vivo platelet activation, and may be responsible for nonenzymatic glycation of platelet glycoproteins, causing changes in their structure and conformation, as well as alterations of membrane lipid dynamics.

Abstract: Furthermore, hyperglycemia-induced oxidative stress is responsible for enhanced peroxidation of arachidonic acid to form biologically active isoprostanes, which represents an important biochemical link between impaired glycemic control and persistent platelet activation.

Abstract: Finally, increased oxidative stress is responsible for activation of transcription factors and expression of redox-sensitive genes leading to a phenotypic switch of endothelium toward an adhesive, pro-thrombotic condition, initial platelet activation, adhesion and subsequent platelet aggregate formation.

Abstract: All this evidence is strengthened by the results of clinical trials documenting the beneficial effects of metabolic control on platelet function, and by the finding that aspirin treatment may even be more beneficial in diabetic than in high-risk non-diabetic patients.

Abstract: Attention to appropriate medical management of diabetic patients will have great impact on long-term outcome in this high-risk population.


Nicotinic receptor-mediated neuroprotection in neurodegenerative disease models.

Abstract: Multiple lines of evidence, from molecular and cellular to epidemiological, have implicated nicotinic transmission in the pathology of Alzheimer's disease (AD) and Parkinson's disease (PD).

Abstract: This review article presents evidence for nicotinic acetylcholine receptor (nAChR)-mediated protection and the signal transduction involved in this mechanism.

Abstract: The data is based mainly on our studies using rat-cultured primary neurons.

Abstract: Nicotine-induced protection was blocked by an alpha7 nAChR antagonist, a phosphatidylinositol 3-kinase (PI3K) inhibitor, and an Src inhibitor.

Abstract: Levels of phosphorylated Akt, an effector of PI3K, Bcl-2 and Bcl-x were increased by nicotine administration.

Abstract: From these experimental data, our hypothesis for the mechanism of nAChR-mediated survival signal transduction is that the alpha7 nAChR stimulates the Src family, which activates PI3K to phosphorylate Akt, which subsequently transmits the signal to up-regulate Bcl-2 and Bcl-x.

Abstract: Up-regulation of Bcl-2 and Bcl-x could prevent cells from neuronal death induced by beta-amyloid (Abeta), glutamate and rotenone.

Abstract: These findings suggest that protective therapy with nAChR stimulation could delay the progress of neurodegenerative diseases such as AD and PD.


High-throughput parallel proteogenomics: a bacterial case study.

Abstract: In recent years, a new paradigm for genome annotation has emerged, termed "proteogenomics," that leverages peptide MS to annotate a genome.

Abstract: This is achieved by mapping peptides to a six-frame translation of a genome, including available splice databases, which may suggest refinements to gene models.

Abstract: Using this approach, it is possible to refine gene regions such as exon boundaries, novel genes, gene boundaries, frame shifts, reverse strands, translated UTRs, and novel splice junctions.

Abstract: One of the challenges of proteogenomics is how best to (1) tackle assigning confidence to any resulting annotation and (2) apply these gene model refinements, either through manual annotation or through an automated process via training gene prediction tools.

Abstract: This is not a straightforward process, as many gene prediction tools have their defined suitability for niche genomes (either eukaryotic or prokaryotic) trained on and refined with model organisms such as Arabidopsis thaliana and Escherichia coli, and varying degrees of features that can leverage the use of external evidence.

Abstract: In this study, we outline a suitable approach toward preprocessing mass spectra and optimizing the MS/MS search for a given dataset.

Abstract: We also discuss future challenges, which continue to pose a problem in the field of proteogenomics, and better strategies to successfully tackle them with, using existing tools.

Abstract: We use Bradyrhizobium diazoefficiens (Nitrogen-fixing bacteria), with a 9.1 Mb genome as a case study, utilizing the latest in second-generation proteogenomics tools with multiple gene models for cross-validation of proteogenomics annotations.


Keratinocyte-specific transglutaminase of cultured human epidermal cells: relation to cross-linked envelope formation and terminal differentiation.

Abstract: The predominant form of the cross-linking enzyme, transglutaminase, in cultured normal human epidermal keratinocytes, is found in cell particulate material and can be solubilized by nonionic detergent.

Abstract: It elutes as a single peak upon either anion-exchange or gel-filtration chromatography.

Abstract: Monoclonal antibodies raised to the particulate enzyme cross-react with one of two transglutaminases in the cell cytosol.

Abstract: The second cytosolic transglutaminase, which has distinct kinetic and physical properties from the first, does not cross-react and is not essential for formation of the keratinocyte cross-linked envelope in vitro.

Abstract: The anti-transglutaminase antibodies stain the more differentiated layers of epidermis in a pattern similar to that given by anti-involucrin antiserum.

Abstract: These observations support the hypothesis that the transglutaminase so identified is involved in cross-linked envelope formation in vivo.


The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.

Abstract: The aim of this study was to compare the effects of the genetic and pharmacological disruption of CB1 cannabinoid receptors on the elevated plus-maze test of anxiety.

Abstract: In the first experiment, the behaviour of CB1-knockout mice and wild-type mice was compared.

Abstract: In the second experiment, the cannabinoid antagonist SR141716A (0, 1, and 3 mg/kg) was administered to both CB1-knockout and wild type mice.

Abstract: Untreated CB1-knockout mice showed a reduced exploration of the open arms of the plus-maze apparatus, thus appearing more anxious than the wild-type animals, however no changes in locomotion were noticed.

Abstract: The vehicle-injected CB1-knockout mice from the second experiment also showed increased anxiety as compared with wild types.

Abstract: Surprisingly, the cannabinoid antagonist SR141716A reduced anxiety in both wild type and CB1 knockout mice.

Abstract: Locomotor behaviour was only marginally affected.

Abstract: Recent evidence suggests the existence of a novel cannabinoid receptor in the brain.

Abstract: It has also been shown that SR141716A binds to both the CB1 and the putative novel receptor.

Abstract: The data presented here supports these findings, as the cannabinoid receptor antagonist affected anxiety in both wild type and CB1-knockout mice.

Abstract: Tentatively, it may be suggested that the discrepancy between the effects of the genetic and pharmacological blockade of the CB1 receptor suggests that the novel receptor plays a role in anxiety.


Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Abstract: Despite complete or near-complete suppression of human immunodeficiency virus (HIV) replication with combination antiretroviral therapy, both HIV and chronic inflammation/immune dysfunction persist indefinitely.

Abstract: Untangling the association between the virus and the host immune environment during therapy might lead to novel interventions aimed at either curing the infection or preventing the development of inflammation-associated end-organ disease.

Abstract: Chronic inflammation and immune dysfunction might lead to HIV persistence by causing virus production, generating new target cells, enabling infecting of activated and resting target cells, altering the migration patterns of susceptible target cells, increasing the proliferation of infected cells, and preventing normal HIV-specific clearance mechanisms from function.

Abstract: Chronic HIV production or replication might contribute to persistent inflammation and immune dysfunction.

Abstract: The rapidly evolving data on these issues strongly suggest that a vicious cycle might exist in which HIV persistence causes inflammation that in turn contributes to HIV persistence.


Tissue-specific alterations in the glucocorticoid sensitivity of immune cells following repeated social defeat in mice

Abstract: Endogenous glucocorticoids (GC) play an important role in the termination of the inflammatory response following infection and tissue injury.

Abstract: However, recent findings indicate that stress can impair the anti-inflammatory capacities of these hormones.

Abstract: Lipopolysaccharide (LPS)-stimulated splenocytes of mice that were repeatedly subjected to social disruption (SDR) stress were less sensitive to the immunosuppressive effects of corticosterone (CORT) as demonstrated by an increased production of pro-inflammatory cytokines and enhanced cell survival.

Abstract: Myeloid cells expressing the marker CD11b were shown to play a key role in this process.

Abstract: Here we investigated the role of the bone marrow as a potential source of the GC-insensitive cells.

Abstract: The study revealed that LPS-stimulated bone marrow cells, in the absence of experimental stress, were virtually GC-resistant and retained high levels of cell viability after treatment with CORT.

Abstract: Recurrent exposure to the acute stressor over a period of 2, 4 or 6 days led to an increase in the GC sensitivity of the bone marrow cells.

Abstract: This increase in GC sensitivity was associated with enhanced mRNA expression of granulocyte-macrophage colony-stimulating factor (GM-CSF), an increase in the number of myeloid progenitors, and a decrease in the proportion of mature CD11b+ cells.

Abstract: The changes in the cellular composition of the bone marrow were accompanied by an increase in splenic CD11b+ cell numbers.

Abstract: Simultaneous assessment of the GC sensitivity in bone marrow and spleen revealed a significant negative correlation between both tissues suggesting that social stress causes the redistribution of GC-insensitive myeloid cells from the bone marrow to the spleen.


Delays in the diagnosis of lung cancer.

Abstract: BACKGROUND Many patients with lung cancer report delays in diagnosing their disease.

Abstract: This may contribute to advanced stage at diagnosis and poor long term survival.

Abstract: This study explores the delays experienced by patients referred to a regional cancer centre with lung cancer.

Abstract: METHODS A prospective cohort of patients referred with newly diagnosed lung cancer were surveyed over a 3 month period to assess delays in diagnosis.

Abstract: Patients were asked when they first experienced symptoms, saw their doctor, what tests were done, when they saw a specialist and when they started treatment.

Abstract: Descriptive statistics were used to summarize the different time intervals.

Abstract: RESULTS 56 of 73 patients consented (RR 77%).

Abstract: However only 52 patients (30M, 22F) were interviewed as 2 died before being interviewed and two could not be contacted.

Abstract: The mean age was 68yrs.

Abstract: Stage distribution was as follows (IB/IIA 10%, stage IIIA 20%, IIIB/IV 70%).

Abstract: Patients waited a median of 21 days (iqr 7-51d) before seeing a doctor and a further 22d (iqr 0-38d) to complete any investigations.

Abstract: The median time from presentation to specialist referral was 27d (iqr 12-49d) and a further 23.5d (iqr 10-56d) to complete investigations.

Abstract: The median wait to start treatment once patients were seen at the cancer centre was 10d (iqr 2-28d).

Abstract: The overall time from development of first symptoms to starting treatment was 138d (iqr 79-175d).

Abstract: CONCLUSIONS Lung cancer patients experience substantial delays from development of symptoms to first initiating treatment.

Abstract: There is a need to promote awareness of lung cancer symptoms and develop and evaluate rapid assessment clinics for patients with suspected lung cancers.


Calcium and peak bone mass.

Abstract: On the basis of previous epidemiological, clinical and experimental studies, it was demonstrated that adequate calcium intake during growth may influence peak bone mass/density, and may be instrumental in preventing subsequent postmenopausal and senile osteoporosis.

Abstract: Calcium intake during adolescence appears to affect skeletal calcium retention directly, and a calcium intake of up to 1600 mg d-1 may be required.

Abstract: Therefore, adolescent females at the time of puberty probably represent the optimal population for early prevention of osteoporosis with calcium.

Abstract: Young individuals must be in positive calcium balance to provide the calcium necessary for skeletal modelling and consolidation, but the degree of positive balance required to achieve peak bone mass and density is unknown.

Abstract: To assess calcium requirements in young individuals, and also to evaluate the determinants of calcium metabolism during the period of acquisition of peak bone mass, 487 calcium balances from previously published reports have been collected and analysed according to developmental phase and calcium intake.

Abstract: The results of this analysis showed that calcium intake and skeletal modelling/turnover are the most important determinants of calcium balance during growth.

Abstract: The highest requirements for calcium are during infancy and adolescence, and then during childhood and young adulthood.

Abstract: Infants (adequate vitamin D supply) and adolescents have higher calcium absorption than children and young adults to meet their high calcium requirements.

Abstract: Calcium absorption during the periods of rapid bone modelling/turnover is probably mediated by Nicolaysen's endogenous factor.

Abstract: Urinary calcium increases with age, and reaches a maximum by the end of puberty.

Abstract: The results also show that calcium intake has little effect on urinary calcium excretion during the period of most rapid skeletal formation: a weak correlation is present in children and young adults.

Abstract: On the basis of the above studies it was suggested that the RDA for calcium should be higher than currently established for children, adolescents, and young adults, in order to ensure a level of skeletal retention of calcium sufficient for maximal peak bone mass.

Abstract: In addition to nutrition, heredity (both parents) and endocrine factors (sexual development) appear to have profound effects on peak bone mass formation.

Abstract: Most of the skeletal mass will be accumulated by late adolescence, indicating early timing of peak bone mass.


Most clinical tests cannot accurately diagnose rotator cuff pathology: a systematic review.

Abstract: QUESTION Do clinical tests accurately diagnose rotator cuff pathology?

Abstract: DESIGN A systematic review of investigations into the diagnostic accuracy of clinical tests for rotator cuff pathology.

Abstract: PARTICIPANTS People with shoulder pain who underwent clinical testing in order to diagnose rotator cuff pathology.

Abstract: OUTCOME MEASURES The diagnostic accuracy of clinical tests was determined using likelihood ratios.

Abstract: RESULTS Thirteen studies met the inclusion criteria.

Abstract: The 13 studies evaluated 14 clinical tests in 89 separate evaluations of diagnostic accuracy.

Abstract: Only one evaluation, palpation for supraspinatus ruptures, resulted in significant positive and negative likelihood ratios.

Abstract: Eight of the 89 evaluations resulted in either significant positive or negative likelihood ratios.

Abstract: However, none of these eight positive or negative likelihood ratios were found in other studies.

Abstract: Of the 89 evaluations of clinical tests 71 (80%) did not result in either significant positive or negative likelihood ratio evaluations across different studies.

Abstract: CONCLUSION Overall, most tests for rotator cuff pathology were inaccurate and cannot be recommended for clinical use.

Abstract: At best, suspicion of a rotator cuff tear may be heightened by a positive palpation, combined Hawkins/painful arc/infraspinatus test, Napoleon test, lift-off test, belly-press test, or drop-arm test, and it may be reduced by a negative palpation, empty can test or Hawkins-Kennedy test.


Skeletal muscle interleukin‐6 regulates metabolic factors in iWAT during HFD and exercise training

Abstract: OBJECTIVE To investigate the role of skeletal muscle (SkM) interleukin (IL)-6 in the regulation of adipose tissue metabolism.

Abstract: METHODS Muscle-specific IL-6 knockout (IL-6 MKO) and IL-6(loxP/loxP) (Floxed) mice were subjected to standard rodent diet (Chow), high-fat diet (HFD), or HFD in combination with exercise training (HFD ExTr) for 16 weeks.

Abstract: RESULTS Total fat mass increased (P < 0.05) in both genotypes with HFD.

Abstract: However, HFD IL-6 MKO mice had lower (P < 0.05) inguinal adipose tissue (iWAT) mass than HFD Floxed mice.

Abstract: Accordingly, iWAT glucose transporter 4 (GLUT4) protein content, 5'AMP activated protein kinase (AMPK)(Thr172) phosphorylation, and fatty acid synthase (FAS) mRNA content were lower (P < 0.05) in IL-6 MKO than Floxed mice on Chow.

Abstract: In addition, iWAT AMPK(Thr172) and hormone-sensitive lipase (HSL)(Ser565) phosphorylation as well as perilipin protein content was higher (P < 0.05) in HFD IL-6 MKO than HFD Floxed mice, and pyruvate dehydrogenase E1α (PDH-E1α) protein content was higher (P < 0.05) in HFD ExTr IL-6 MKO than HFD ExTr Floxed mice.

Abstract: CONCLUSIONS These findings indicate that SkM IL-6 affects iWAT mass through regulation of glucose uptake capacity as well as lipogenic and lipolytic factors.


Risk of hospitalization or death from ischemic heart disease among British vegetarians and nonvegetarians: results from the EPIC-Oxford cohort study.

Abstract: BACKGROUND Few previous prospective studies have examined differences in incident ischemic heart disease (IHD) risk between vegetarians and nonvegetarians.

Abstract: OBJECTIVE The objective was to examine the association of a vegetarian diet with risk of incident (nonfatal and fatal) IHD.

Abstract: DESIGN A total of 44,561 men and women living in England and Scotland who were enrolled in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Oxford study, of whom 34% consumed a vegetarian diet at baseline, were part of the analysis.

Abstract: Incident cases of IHD were identified through linkage with hospital records and death certificates.

Abstract: Serum lipids and blood pressure measurements were available for 1519 non cases, who were matched to IHD cases by sex and age.

Abstract: IHD risk by vegetarian status was estimated by using multivariate Cox proportional hazards models.

Abstract: RESULTS After an average follow-up of 11.6 y, there were 1235 IHD cases (1066 hospital admissions and 169 deaths).

Abstract: Compared with nonvegetarians, vegetarians had a lower mean BMI [in kg/m(2); -1.2 (95% CI: -1.3, -1.1)], non-HDL-cholesterol concentration [-0.45 (95% CI: -0.60, -0.30) mmol/L], and systolic blood pressure [-3.3 (95% CI: -5.9, -0.7) mm Hg].

Abstract: Vegetarians had a 32% lower risk (HR: 0.68; 95% CI: 0.58, 0.81) of IHD than did nonvegetarians, which was only slightly attenuated after adjustment for BMI and did not differ materially by sex, age, BMI, smoking, or the presence of IHD risk factors.

Abstract: CONCLUSION Consuming a vegetarian diet was associated with lower IHD risk, a finding that is probably mediated by differences in non-HDL cholesterol, and systolic blood pressure.


The Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) initiative: a country-driven, multi-partner program to support evidence-based decision making.

Abstract: Multiple health priorities, limited human resources and logistical capacities, as well as expensive vaccines with limited funds available increase the need for evidence-based decision making in immunization programs.

Abstract: The aim of the Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) Initiative is to support countries in the establishment or strengthening of National Immunization Technical Advisory Groups (NITAGs) that provide recommendations on immunization policies and programs (e.g., vaccination schedules, improvements of routine immunization coverage, new vaccine introduction, etc.).

Abstract: SIVAC, a program funded by the Bill & Melinda Gates Foundation, is based on a country-driven, step-by-step process that ensures its support is tailored to country needs and emphasizes NITAG sustainability.

Abstract: SIVAC supports countries by reinforcing the capacities of the NITAG scientific and technical secretariat and by providing specific support activities established in consultation with the country and other international partners.

Abstract: Additionally, SIVAC and partners have built an electronic platform, the NITAG Resource Center, that provides information, tools, and briefings to NITAGs and the immunization community.


Redox-relevant aspects of the extracellular matrix and its cellular contacts via integrins.

Abstract: SIGNIFICANCE The extracellular matrix (ECM) fulfills essential functions in multicellular organisms.

Abstract: It provides the mechanical scaffold and environmental cues to cells.

Abstract: Upon cell attachment, the ECM signals into the cells.

Abstract: In this process, reactive oxygen species (ROS) are physiologically used as signalizing molecules.

Abstract: RECENT ADVANCES ECM attachment influences the ROS-production of cells.

Abstract: In turn, ROS affect the production, assembly and turnover of the ECM during wound healing and matrix remodeling.

Abstract: Pathological changes of ROS levels lead to excess ECM production and increased tissue contraction in fibrotic disorders and desmoplastic tumors.

Abstract: Integrins are cell adhesion molecules which mediate cell adhesion and force transmission between cells and the ECM.

Abstract: They have been identified as a target of redox-regulation by ROS.

Abstract: Cysteine-based redox-modifications, together with structural data, highlighted particular regions within integrin heterodimers that may be subject to redox-dependent conformational changes along with an alteration of integrin binding activity.

Abstract: CRITICAL ISSUES In a molecular model, a long-range disulfide-bridge within the integrin β-subunit and disulfide bridges within the genu and calf-2 domains of the integrin α-subunit may control the transition between the bent/inactive and upright/active conformation of the integrin ectodomain.

Abstract: These thiol-based intramolecular cross-linkages occur in the stalk domain of both integrin subunits, whereas the ligand-binding integrin headpiece is apparently unaffected by redox-regulation.

Abstract: FUTURE DIRECTIONS Redox-regulation of the integrin activation state may explain the effect of ROS in physiological processes.

Abstract: A deeper understanding of the underlying mechanism may open new prospects for the treatment of fibrotic disorders.


Prevalence of hypertension and pre-hypertension among adolescents.

Abstract: OBJECTIVE To determine the prevalence of hypertension and pre-hypertension on the basis of the 2004 National High Blood Pressure Education Program Working Group guidelines in an adolescent school-screening population.

Abstract: STUDY DESIGN Cross-sectional assessment of blood pressure (BP) in 6790 adolescents (11-17 years) in Houston schools was conducted from 2003 to 2005.

Abstract: Initial measurements included height, weight, and 4 oscillometric BP readings.

Abstract: Repeat measurements were obtained on 2 subsequent occasions in students with persistently elevated BP.

Abstract: Final prevalence was adjusted for loss to follow-up and logistic regression used to assess risk factors.

Abstract: RESULTS BP distribution at initial screen was 81.1% normal, 9.5% pre-hypertension, and 9.4% hypertension (8.4% Stage 1; 1% Stage 2).

Abstract: Prevalence after 3 screenings was 81.1% normal, 15.7% pre-hypertension, and 3.2% hypertension (2.6% Stage 1; 0.6% Stage 2).

Abstract: Hypertension and pre-hypertension increased with increasing body mass index.

Abstract: Sex, race, and classification as either at-risk for overweight or overweight were independently associated with pre-hypertension.

Abstract: Only classification as overweight was associated with hypertension.

Abstract: CONCLUSIONS Application of new classification guidelines for adolescents with elevated BP reveals approximately 20% are at risk for hypertension.

Abstract: Further research determining the significance of each BP category and refining definitions to account for BP variability is warranted.


Increased short- and long-term risk of inflammatory bowel disease after salmonella or campylobacter gastroenteritis.

Abstract: BACKGROUND & AIMS Various commensal enteric and potentially pathogenic bacteria may be involved in the pathogenesis of inflammatory bowel diseases (IBD).

Abstract: We compared the risk of IBD between a cohort of patients with documented Salmonella or Campylobacter gastroenteritis and an age- and gender-matched control group from the same population in Denmark.

Abstract: METHODS We identified 13,324 patients with Salmonella/Campylobacter gastroenteritis from laboratory registries in North Jutland and Aarhus counties, Denmark, from 1991 through 2003, and 26,648 unexposed controls from the same counties.

Abstract: Of these, 176 exposed patients with IBD before the infection, their 352 unexposed controls, and 80 unexposed individuals with IBD before the Salmonella/Campylobacter infection were excluded.

Abstract: The final study cohort of 13,148 exposed and 26,216 unexposed individuals were followed for up to 15 years (mean, 7.5 years).

Abstract: RESULTS A first-time diagnosis of IBD was reported in 107 exposed (1.2%) and 73 unexposed individuals (0.5%).

Abstract: By age, gender, and comorbidity adjusted Cox proportional hazards regression analysis, the hazard ratio (95% confidence interval) for IBD was 2.9 (2.2-3.9) for the whole period and 1.9 (1.4-2.6) if the first year after the Salmonella/Campylobacter infection was excluded.

Abstract: The increased risk in exposed subjects was observed throughout the 15-year observation period.

Abstract: The increased risk was similar for Salmonella (n = 6463) and Campylobacter (n = 6685) and for a first-time diagnosis of Crohn's disease (n = 47) and ulcerative colitis (n = 133).

Abstract: CONCLUSIONS In our population-based cohort study with complete follow-up, an increased risk of IBD was demonstrated in individuals notified in laboratory registries with an episode of Salmonella/Campylobacter gastroenteritis.


Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx.

Abstract: A long-term cell culture epithelioid cell line was established from a recurrent squamous carcinoma of the nasopharynx of a Chinese male 17 1/2 years after radiation therapy.

Abstract: The cell line, designated NPC/HK1, has been passed 72 times over a period 1 year.

Abstract: The cells have been shown by light and electron microscopies to be of the squamous epithelial type.

Abstract: When they were transplanted subcutaneously into the back of athymic nude BALB/c (nu/nu) mice, tumors developed at the sites of inoculation, which on histological examination were shown to be well-differentiated squamous carcinomas, similar in morphology to the recurrent human tumor from which they were derived.

Abstract: Karyotypic analysis of cells from the cell line demonstrates an aneuploid human type with a modal chromosome number of 74 with both numerical and structural aberrations.

Abstract: Viral particles or Epstein-Barr viral nuclear antigen (EBNA) has not been demonstrated in the cells from the primary culture or several of the subcultures tested.

Abstract: The presence of EBNA in touch smears prepared from the biopsy tissue was inconclusive.

Abstract: Infection of the subcultured cells with EBV from P3HR1 and B95-8 cells was unsuccessful.


Effect of lipid restriction on mitochondrial free radical production and oxidative DNA damage.

Abstract: Many studies have shown that caloric restriction (40%) decreases mitochondrial reactive oxygen species (ROS) generation in rodents.

Abstract: Moreover, we have recently found that 7 weeks of 40% protein restriction without strong caloric restriction also decreases ROS production in rat liver.

Abstract: This is interesting since it has been reported that protein restriction can also extend longevity in rodents.

Abstract: In the present study we have investigated the possible role of dietary lipids in the effects of caloric restriction on mitochondrial oxidative stress.

Abstract: Using semipurified diets, the ingestion of lipids in male Wistar rats was decreased by 40% below controls, while the other dietary components were ingested at exactly the same level as in animals fed ad libitum.

Abstract: After 7 weeks of treatment the liver mitochondria of lipid-restricted animals showed significant increases in oxygen consumption with complex I-linked substrates (pyruvate/malate and glutamate/malate).

Abstract: Neither mitochondrial H(2)O(2) production nor oxidative damage to mitochondrial or nuclear DNA was modified in lipid-restricted animals.

Abstract: Oxidative damage to mitochondrial DNA was one order of magnitude higher than that of nuclear DNA in both dietary groups.

Abstract: These results deny a role for lipids and reinforce the possible role of dietary proteins as being responsible for the decrease in mitochondrial ROS production and DNA damage in caloric restriction.


Kruppel-like factor 2 is a transcriptional regulator of chronic and acute inflammation.

Abstract: Although myeloid cell activation is requisite for an optimal innate immune response, this process must be tightly controlled to prevent collateral host tissue damage.

Abstract: Kruppel-like factor 2 (KLF2) is a potent regulator of myeloid cell proinflammatory activation.

Abstract: As an approximately 30% to 50% reduction in KLF2 levels has been observed in human subjects with acute or chronic inflammatory disorders, we studied the biological response to inflammation in KLF2(+/-) mice.

Abstract: Herein, we show that partial deficiency of KLF2 modulates the in vivo response to acute (sepsis) and subacute (skin) inflammatory challenge.

Abstract: Mechanistically, we link the anti-inflammatory effects of KLF2 to the inhibition of NF-κB transcriptional activity.

Abstract: Collectively, the observations provide biologically relevant insights into KLF2-mediated modulation of these inflammatory processes that could potentially be manipulated for therapeutic gain.


Simian immunodeficiency viruses replication dynamics in African non-human primate hosts: common patterns and species-specific differences.

Abstract: METHODS To define potential common features of simian immunodeficiency virus (SIV) infections in different naturally infected host species, we compared the dynamics of viral replication in 31 African green monkeys (10 sabeus, 15 vervets and seven Caribbean AGMs), 14 mandrills and three sooty mangabeys (SMs) that were experimentally infected with their species-specific viruses.

Abstract: RESULTS After infection, these SIVs replicated rapidly reaching viral loads (VLs) of 10(5)-10(9) copies/ml of plasma between days 9-14 post-infection (p.i).

Abstract: Set point viremia was established between days 42 and 60 p.i., with levels of approximately 10(5)-10(6) copies/ml in SM and mandrills, and lower levels (10(3)-10(5) copies/ml) in AGMs.

Abstract: VL during the chronic phase did not correlate with viral genome structure: SIVmnd-2 (a vpx-containing virus) and SIVmnd-1 (which does not contain vpu or vpx) replicated to similar levels in mandrills.

Abstract: VL was dependent on virus strain: vervets infected with three different viral strains showed different patterns of viral replication.

Abstract: The pattern of viral replication of SIVagm.sab, which uses both CCR5 and CXCR4 co-receptors was similar to those of the other viruses.

Abstract: CONCLUSIONS Our results show a common pattern of SIV replication in naturally and experimentally infected hosts.

Abstract: This is similar overall to that observed in pathogenic SIV infection of macaques.

Abstract: This result indicates that differences in clinical outcome between pathogenic and non-pathogenic infections rely on host responses rather than the characteristics of the virus itself.


The role of the transcription factor KLF2 in vascular development and disease.

Abstract: The zinc-finger transcription factor KLF2 transduces the physical forces exerted by blood flow into molecular signals responsible for a wide range of biological responses.

Abstract: Following its initial recognition as a flow-responsive endothelial transcription factor, KLF2 is now known to be expressed in a range of cell types and to participate in a number of processes during development and disease such as endothelial homeostasis, vasoregulation, vascular growth/remodeling, and inflammation.

Abstract: In this review, we summarize the current understanding about KLF2 with a focus on its effects on vascular biology.


Implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a report from the GReek AntiPlatelet rEgistry (GRAPE).

Abstract: BACKGROUND Few data exist about the implementation of contemporary oral antiplatelet treatment guidelines in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI).

Abstract: METHODS GReek AntiPlatelet rEgistry (GRAPE), initiated on January 2012, is a prospective, observational, multicenter cohort study focusing on contemporary use of P2Y12 inhibitors.

Abstract: In 1434 patients we evaluated appropriateness of P2Y12 selection initially and at discharge by applying an eligibility-assessing algorithm based on P2Y12 inhibitors' contraindications/specific warnings and precautions.

Abstract: RESULTS Appropriate, less preferable and inappropriate P2Y12 inhibitor selections were made initially in 45.8%, 47.2% and 6.6% and at discharge in 64.1%, 29.2% and 6.6% of patients, respectively.

Abstract: The selection of clopidogrel was most commonly less preferable, both initially (69.7%) and at discharge (75.6%).

Abstract: Appropriate selection of newer agents was high initially (79.2%-82.8%), with further increase as selection at discharge (89.4%-89.8%).

Abstract: Inappropriate selection of the newer agents was 17.2%-20.8% initially, decreasing to 10.2%-10.6% at discharge.

Abstract: Conditions and co-medications related to increased bleeding risk, presentation with ST elevation myocardial infarction and the absence of reperfusion within the first 24h were the most powerful predictors of appropriate P2Y12 selection initially, whereas age ≥75 years, conditions and co-medications related to increased bleeding risk and regional trends mostly affected appropriate P2Y12 selection at discharge.

Abstract: CONCLUSIONS In GRAPE, adherence with the recently released guidelines on oral antiplatelet therapy was satisfactory.

Abstract: Clopidogrel was most commonly used as a less preferable selection, while prasugrel or ticagrelor selection was mostly appropriate.

Abstract: Certain factors may predict initial and at discharge guideline implementation.

Abstract: Clinical Trial Registration-clinicaltrials.gov Identifier: NCT01774955 http://clinicaltrials.gov/.


Comorbidity of depressive and anxiety disorders in chronic daily headache and its subtypes.

Abstract: OBJECTIVE To investigate the frequency of depressive and anxiety disorders in patients with chronic daily headache.

Abstract: BACKGROUND There is a lack of data in the literature on the extent of psychiatric comorbidity in patients with different subtypes of chronic daily headache.

Abstract: METHODS We recruited consecutive patients with chronic daily headache seen in a headache clinic from November 1998 to December 1999.

Abstract: The subtypes of chronic daily headache were classified according to the criteria proposed by Silberstein et al. A psychiatrist evaluated the patients according to the structured Mini-International Neuropsychiatric Interview to assess the comorbidity of depressive and anxiety disorders.

Abstract: RESULTS Two hundred sixty-one patients with chronic daily headache were recruited.

Abstract: The mean age was 46 years, and 80% were women.

Abstract: Transformed migraine was diagnosed in 152 patients (58%) and chronic tension-type headache in 92 patients (35%).

Abstract: Seventy-eight percent of patients with transformed migraine had psychiatric comorbidity, including major depression (57%), dysthymia (11%), panic disorder (30%), and generalized anxiety disorder (8%).

Abstract: Sixty-four percent of patients with chronic tension-type headache had psychiatric diagnoses, including major depression (51%), dysthymia (8%), panic disorder (22%), and generalized anxiety disorder (1%).

Abstract: The frequency of anxiety disorders was significantly higher in patients with transformed migraine after controlling for age and sex (P =.02).

Abstract: Both depressive and anxiety disorders were significantly more frequent in women.

Abstract: CONCLUSION Psychiatric comorbidity, especially major depression and panic disorders, was highly prevalent in patients with chronic daily headache seen in a headache clinic.

Abstract: These results demonstrate that women and patients with transformed migraine are at higher risk of psychiatric comorbidity.


The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription.

Abstract: Although most cytokines are studied for biological effects after engagement of their specific cell surface membrane receptors, increasing evidence suggests that some function in the nucleus.

Abstract: In the present study, the precursor form of IL-1alpha was overexpressed in various cells and assessed for activity in the presence of saturating concentrations of IL-1 receptor antagonist to prevent receptor signaling.

Abstract: Initially diffusely present in the cytoplasm of resting cells, IL-1alpha translocated to the to nucleus after activation by endotoxin, a Toll-like receptor ligand.

Abstract: The IL-1alpha precursor, but not the C-terminal mature form, activated the transcriptional machinery in the GAL4 system by 90-fold; a 50-fold increase was observed using only the IL-1alpha propiece, suggesting that transcriptional activation was localized to the N terminus where the nuclear localization sequence resides.

Abstract: Under conditions of IL-1 receptor blockade, intracellular overexpression of the precursor and propiece forms of IL-1alpha were sufficient to activate NF-kappaB and AP-1.

Abstract: Stable transfectants overproducing precursor IL-1alpha released the cytokines IL-8 and IL-6 but also exhibited a significantly lower threshold of activation to subpicomolar concentrations of tumor necrosis factor alpha or IFN-gamma.

Abstract: Thus, intracellular functions of IL-1alpha might play an unforeseen role in the genesis of inflammation.

Abstract: During disease-driven events, the cytosolic precursor moves to the nucleus, where it augments transcription of proinflammatory genes.

Abstract: Because this mechanism of action is not affected by extracellular inhibitors, reducing intracellular functions of IL-1alpha might prove beneficial in some inflammatory conditions.


Three-dimensional structure of the AAH26994.1 protein from Mus musculus, a putative eukaryotic Urm1.

Abstract: We have used NMR spectroscopy to determine the solution structure of protein AAH26994.1 from Mus musculus and propose that it represents the first three-dimensional structure of a ubiquitin-related modifier 1 (Urm1) protein.

Abstract: Amino acid sequence comparisons indicate that AAH26994.1 belongs to the Urm1 family of ubiquitin-like modifier proteins.

Abstract: The best characterized member of this family has been shown to be involved in nutrient sensing, invasive growth, and budding in yeast.

Abstract: Proteins in this family have only a weak sequence similarity to ubiquitin, and the structure of AAH26994.1 showed a much closer resemblance to MoaD subunits of molybdopterin synthases (known structures are of three bacterial MoaD proteins with 14%-26% sequence identity to AAH26994.1).

Abstract: The structures of AAH26994.1 and the MoaD proteins each contain the signature ubiquitin secondary structure fold, but all differ from ubiquitin largely in regions outside of this fold.

Abstract: This structural similarity bolsters the hypothesis that ubiquitin and ubiquitin-related proteins evolved from a protein-based sulfide donor system of the molybdopterin synthase type.


Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.

Abstract: BACKGROUND Adenocarcinoma of the endometrium is the most common gynecologic malignancy in the United States, accounting for approximately 36,000 diagnoses of invasive carcinoma annually.

Abstract: The most common histologic type, endometrioid adenocarcinoma (EC), accounts for 75-80% of patients.

Abstract: The objective of this work was to estimate the prevalence of concurrent carcinoma in women with a biopsy diagnosis of the precursor lesion, atypical endometrial hyperplasia (AEH).

Abstract: METHODS This prospective cohort study included women who had a community diagnosis of AEH.

Abstract: Diagnostic biopsy specimens were reviewed independently by three gynecologic pathologists who used International Society of Gynecologic Pathologists/World Health Organization criteria.

Abstract: Study participants underwent hysterectomy within 12 weeks of entry onto protocol without interval treatment.

Abstract: The hysterectomy slides also were reviewed by the study pathologists, and their findings were used in the subsequent analyses.

Abstract: RESULTS Between November 1998 and June 2003, 306 women were enrolled on the study.

Abstract: Of these, 17 women were not included in the analysis: Two patients had unreadable slides because of poor processing or insufficient tissue, 2 patients had only slides that were not endometrial, the slides for 5 patients were not available for review, and 8 of the hysterectomy specimens were excluded because they showed evidence of interval intervention, either progestin effect or ablation.

Abstract: In total, 289 patients were included in the current analysis.

Abstract: The study panel review of the AEH biopsy specimens was interpreted as follows: 74 of 289 specimens (25.6%) were diagnosed as less than AEH, 115 of 289 specimens (39.8%) were diagnosed as AEH, and 84 of 289 specimens (29.1%) were diagnosed as endometrial carcinoma.

Abstract: In 5.5% (16 of 289 specimens), there was no consensus on the biopsy diagnosis.

Abstract: The rate of concurrent endometrial carcinoma for analyzed specimens was 42.6% (123 of 289 specimens).

Abstract: Of these, 30.9% (38 of 123 specimens) were myoinvasive, and 10.6% (13 of 123 specimens) involved the outer 50% of the myometrium.

Abstract: Among the women who had hysterectomy specimens with carcinoma, 14 of 74 women (18.9%) had a study panel biopsy consensus diagnosis of less than AEH, 45 of 115 women (39.1%) had a study panel biopsy consensus diagnosis of AEH, and 54 of 84 women (64.3%) had a study panel diagnosis of carcinoma.

Abstract: Among women who had no consensus in their biopsy diagnosis, 10 of 16 women (62.5%) had carcinoma in their hysterectomy specimens.

Abstract: CONCLUSIONS The prevalence of endometrial carcinoma in patients who had a community hospital biopsy diagnosis of AEH was high (42.6%).

Abstract: When considering management strategies for women who have a biopsy diagnosis of AEH, clinicians and patients should take into account the considerable rate of concurrent carcinoma.


The prevalence and clustering of four major lifestyle risk factors in an English adult population.

Abstract: BACKGROUND The aim of this study was to examine the clustering of four major lifestyle risk factors (smoking, heavy drinking, lack of fruit and vegetables consumption, and lack of physical activity), and to examine the variation across different socio-demographic groups in the English adult population.

Abstract: METHODS The study population was derived from the 2003 Health Survey for England (n=11,492).

Abstract: Clustering was examined by comparing the observed and expected prevalence of the different possible combinations.

Abstract: A multinomial multilevel regression model was conducted to examine the socio-demographic variation in the clustering of the four risk factors.

Abstract: RESULTS The study found that, when using British health recommendations, a majority of the English population have multiple lifestyle risk factors at the same time.

Abstract: Clustering was found at both ends of the lifestyle spectrum and was more pronounced for women than for men.

Abstract: Overall, multiple risk factors were more prevalent among men, lower social class households, singles, and people who are economically inactive, but less prevalent among home owners and older age groups.

Abstract: CONCLUSIONS The clustering of multiple risk factors provides support for multiple-behavior interventions as opposed to single-behavior interventions.


Cutting edge: interleukin 17 signals through a heteromeric receptor complex.

Abstract: IL-17 is an inflammatory cytokine produced primarily by a unique lineage of CD4 T cells that plays critical roles in the pathogenesis of multiple autoimmune diseases.

Abstract: IL-17RA is a ubiquitously expressed receptor that is essential for IL-17 biologic activity.

Abstract: Despite widespread receptor expression, the activity of IL-17 is most classically defined by its ability to induce the expression of inflammatory cytokines, chemokines, and other mediators by stromal cells.

Abstract: The lack of IL-17 responsiveness in mouse stromal cells genetically deficient in IL-17RA is poorly complemented by human IL-17RA, suggesting the presence of an obligate ancillary component whose activity is species specific.

Abstract: This component is IL-17RC, a distinct member of the IL-17R family.

Abstract: Thus, the biologic activity of IL-17 is dependent on a complex composed of IL-17RA and IL-17RC, suggesting a new paradigm for understanding the interactions between the expanded family of IL-17 ligands and their receptors.


Long non-coding RNAs with low expression levels in cells are enriched in secreted exosomes.

Abstract: Long non-coding RNAs (lncRNAs) are involved in regulating chromatin modifications, gene transcription, mRNA translation, and protein function.

Abstract: We recently reported a high variation in the basal expression levels of a panel of lncRNAs in HeLa and MCF-7 cells and their differential response to DNA damage induction.

Abstract: Here, we hypothesized that lncRNA molecules with different cellular expression may have a differential abundance in secreted exosomes, and their exosome levels would reflect cellular response to DNA damage.

Abstract: MALAT1, HOTAIR, lincRNA-p21, GAS5, TUG1, CCND1-ncRNA in exosomes secreted from cultured cells were characterized.

Abstract: A different expression pattern of lncRNAs in exosomes was seen compared to cells.

Abstract: RNA molecules with relative low expression levels (lincRNA-p21, HOTAIR, ncRNA-CCND1) were highly enriched in exosomes.

Abstract: TUG1 and GAS5 levels were moderately elevated in exosomes, whereas MALAT1--which was the most abundant molecule in cells--was present at levels comparable to its cellular levels.

Abstract: lincRNA-p21 and ncRNA-CCND1 were the main molecules; exosome levels of them best reflect the change of their cellular levels upon exposure of the cells to bleomycin-induced DNA damage.

Abstract: In conclusion, we provide evidence that lncRNAs have a differential abundance in exosomes, indicating a selective loading.


Olanzapine depot exposure in male rats: Dose-dependent lipogenic effects without concomitant weight gain.

Abstract: Treatment with second-generation antipsychotic agents such as olanzapine frequently results in metabolic adverse effects, e.g. hyperphagia, weight gain and dyslipidaemia in patients of both genders.

Abstract: The molecular mechanisms underlying metabolic adverse effects are still largely unknown, and studies in rodents represent an important approach in their exploration.

Abstract: However, the validity of the rodent model is hampered by the fact that antipsychotics induce weight gain in female, but not male, rats.

Abstract: When administered orally, the short half-life of olanzapine in rats prevents stable plasma concentrations of the drug.

Abstract: We recently showed that a single intramuscular injection of long-acting olanzapine formulation yields clinically relevant plasma concentrations accompanied by several dysmetabolic features in the female rat.

Abstract: In the current study, we show that depot injections of 100-250 mg/kg olanzapine yielded clinically relevant plasma olanzapine concentrations also in male rats.

Abstract: In spite of transient hyperphagia, however, olanzapine resulted in weight loss rather than weight gain.

Abstract: The resultant negative feed efficiency was accompanied by a slight elevation of thermogenesis markers in brown adipose tissue for the highest olanzapine dose, but the olanzapine-related reduction in weight gain remains to be explained.

Abstract: In spite of the absence of weight gain, an olanzapine dose of 200mg/kg or above induced significantly elevated plasma cholesterol levels and pronounced activation of lipogenic gene expression in the liver.

Abstract: These results confirm that olanzapine stimulates lipogenic effects, independent of weight gain, and raise the possibility that endocrine factors may influence gender specificity of metabolic effects of antipsychotics in the rat.


Glutamate mediates the function of melanocortin receptor 4 on Sim1 neurons in body weight regulation.

Abstract: The melanocortin receptor 4 (MC4R) is a well-established mediator of body weight homeostasis.

Abstract: However, the neurotransmitter(s) that mediate MC4R function remain largely unknown; as a result, little is known about the second-order neurons of the MC4R neural pathway.

Abstract: Single-minded 1 (Sim1)-expressing brain regions, which include the paraventricular nucleus of hypothalamus (PVH), represent key brain sites that mediate melanocortin action.

Abstract: We conditionally restored MC4R expression in Sim1 neurons in the background of Mc4r-null mice.

Abstract: The restoration dramatically reduced obesity in Mc4r-null mice.

Abstract: The anti-obesity effect was completely reversed by selective disruption of glutamate release from those same Sim1 neurons.

Abstract: The reversal was caused by lower energy expenditure and hyperphagia.

Abstract: Corroboratively, selective disruption of glutamate release from adult PVH neurons led to rapid obesity development via reduced energy expenditure and hyperphagia.

Abstract: Thus, this study establishes glutamate as the primary neurotransmitter that mediates MC4Rs on Sim1 neurons in body weight regulation.


Intracellular sterol dynamics.

Abstract: We review the cellular mechanisms implicated in cholesterol trafficking and distribution.

Abstract: Recent studies have provided new information about the distribution of sterols within cells, including analysis of its transbilayer distribution.

Abstract: The cholesterol interaction with other lipids and its engagement in various trafficking processes will determine its proper level in a specific membrane; making the cholesterol distribution uneven among the various intracellular organelles.

Abstract: The cholesterol content is important since cholesterol plays an essential role in membranes by controlling their physicochemical properties as well as key cellular events such as signal transduction and protein trafficking.

Abstract: Cholesterol movement between cellular organelles is highly dynamic, and can be achieved by vesicular and non-vesicular processes.

Abstract: Various studies have analyzed the proteins that play a significant role in these processes, giving us new information about the relative importance of these two trafficking pathways in cholesterol transport.

Abstract: Although still poorly characterized in many trafficking routes, several potential sterol transport proteins have been described in detail; as a result, molecular mechanisms for sterol transport among membranes start to be appreciated.


A plasma membrane component able to bind and alter virions of poliovirus type 1: studies on cell-free alteration using a simplified assay.

Abstract: Abstract Intact HeLa cells can bind virions of poliovirus type 1 and can subsequently convert them to altered particles by incubation at 37°.

Abstract: Altered particles sediment more slowly than virions, have lost VP-4, and are disrupted by sodium dodecyl sulfate, but their RNA is intact and ribonuclease insensitive.

Abstract: These characteristics allow assay of altered particles and of particles that have released their RNA, using nuclease digestion with or without sodium dodecyl sulfate treatment.

Abstract: With this simple assay procedure, quantitative parameters of binding and alteration can be measured.

Abstract: The binding-altering activity can be localized in plasma membranes, and pure membranes can be shown to carry out alteration.

Abstract: The membrane-bound activity is abolished by proteases and by nonionic detergents.

Abstract: Only altered particles are formed by membranes; release of RNA is not caused by membranes but is caused by intact cells.

Abstract: Binding and alteration are processes that are closely associated; it is possible that alteration is a consequence of binding by multiple receptors in a fluid membrane.


Resequencing studies of nonmodel organisms using closely related reference genomes: optimal experimental designs and bioinformatics approaches for population genomics.

Abstract: Decreasing costs of next-generation sequencing (NGS) experiments have made a wide range of genomic questions open for study with nonmodel organisms.

Abstract: However, experimental designs and analysis of NGS data from less well-known species are challenging because of the lack of genomic resources.

Abstract: In this work, we investigate the performance of alternative experimental designs and bioinformatics approaches in estimating variability and neutrality tests based on the site-frequency-spectrum (SFS) from individual resequencing data.

Abstract: We pay particular attention to challenges faced in the study of nonmodel organisms, in particular the absence of a species-specific reference genome, although phylogenetically close genomes are assumed to be available.

Abstract: We compare the performance of three alternative bioinformatics approaches – genotype calling, genotype–haplotype calling and direct estimation without calling genotypes.

Abstract: We find that relying on genotype calls provides biased estimates of population genetic statistics at low to moderate read depth (2–8X).

Abstract: Genotype–haplotype calling returns more accurate estimates irrespective of the divergence to the reference genome, but requires moderate depth (8–20X).

Abstract: Direct estimation without calling genotypes returns the most accurate estimates of variability and of most SFS tests investigated, including at low read depth (2–4X).

Abstract: Studies without species-specific reference genome should thus aim for low read depth and avoid genotype calling whenever individual genotypes are not essential.

Abstract: Otherwise, aiming for moderate to high depth at the expense of number of individuals, and using genotype–haplotype calling, is recommended.


Thalassemia and malaria: new insights into an old problem.

Abstract: The hemoglobinopathies are probably the world's most common genetic diseases: The World Health Organization has estimated that at least 5% of the population are carriers for one or other of the most serious forms, the alpha- and beta-thalassemias and the structural variant hemoglobins S, C, and E, which are found at polymorphic frequencies in many countries.

Abstract: All these hemoglobinopathies are believed to provide protection against malaria, and it is thought that, in malarial regions of the world, natural selection has been responsible for elevating and maintaining their gene frequencies, an idea first proposed 50 years ago by J.B.S. Haldane.

Abstract: Epidemiological studies undertaken in the 1950s on hemoglobin S in Africa provided support for the "malaria hypothesis," but until recently it has proved extremely difficult to verify it for the thalassemias.

Abstract: The application of molecular methods has, however, provided new opportunities to address this old question.

Abstract: Population and molecular genetic analysis of thalassemia variants, and microepidemiological studies of the relationship between alpha-thalassemia and malaria in the southwest Pacific, have provided unequivocal evidence for protection.

Abstract: Surprisingly, some of this protection appears to derive from enhanced susceptibility in very young thalassemic children to both Plasmodium falciparum and, especially, P. vivax, and this early exposure appears to provide the basis for better protection in later life.


Endocrine control of spermatogenesis: Role of FSH and LH/ testosterone.

Abstract: Evaluation of testicular functions (production of sperm and androgens) is an important aspect of preclinical safety assessment and testicular toxicity is comparatively far more common than ovarian toxicity.

Abstract: This chapter focuses (1) on the histological sequelae of disturbed reproductive endocrinology in rat, dog and nonhuman primates and (2) provides a review of our current understanding of the roles of gonadotropins and androgens.

Abstract: The response of the rodent testis to endocrine disturbances is clearly different from that of dog and primates with different germ cell types and spermatogenic stages being affected initially and also that the end-stage spermatogenic involution is more pronounced in dog and primates compared to rodents.

Abstract: Luteinizing hormone (LH)/testosterone and follicle-stimulating hormone (FSH) are the pivotal endocrine factors controlling testicular functions.

Abstract: The relative importance of either hormone is somewhat different between rodents and primates.

Abstract: Generally, however, both LH/testosterone and FSH are necessary for quantitatively normal spermatogenesis, at least in non-seasonal species.


Extravasation injuries on regional neonatal units.

Abstract: This survey of regional neonatal intensive care units determined a prevalence of 38 per 1000 neonates who sustained an extravasation injury that caused skin necrosis.

Abstract: Most injuries occurred in infants of 26 weeks gestation or less, with parenteral nutrition infused through intravenous cannulae.

Abstract: Common treatments were exposing wounds to the air, infiltration with hyaluronidase and saline, and occlusive dressings.


Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus.

Abstract: Hepatitis C virus (HCV) nonstructural protein 3-4A (NS3-4A) is a complex composed of NS3 and its cofactor NS4A.

Abstract: It harbours serine protease as well as NTPase/RNA helicase activities and is essential for viral polyprotein processing, RNA replication and virion formation.

Abstract: Specific inhibitors of the NS3-4A protease significantly improve sustained virological response rates in patients with chronic hepatitis C when combined with pegylated interferon-α and ribavirin.

Abstract: The NS3-4A protease can also target selected cellular proteins, thereby blocking innate immune pathways and modulating growth factor signalling.

Abstract: Hence, NS3-4A is not only an essential component of the viral replication complex and prime target for antiviral intervention but also a key player in the persistence and pathogenesis of HCV.

Abstract: This review provides a concise update on the biochemical and structural aspects of NS3-4A, its role in the pathogenesis of chronic hepatitis C and the clinical development of NS3-4A protease inhibitors.


Phase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease.

Abstract: OBJECTIVE To evaluate the safety, tolerability, and amyloid beta (Abeta) response to the gamma-secretase inhibitor LY450139 in Alzheimer disease.

Abstract: DESIGN Multicenter, randomized, double-blind, dose-escalation, placebo-controlled trial.

Abstract: SETTING Community-based clinical research centers.

Abstract: Patients Fifty-one individuals with mild to moderate Alzheimer disease were randomized to receive placebo (n=15) or LY450139 (100 mg [n=22] or 140 mg [n=14]), with 43 completing the treatment phase.

Abstract: Intervention The LY450139 groups received 60 mg/d for 2 weeks, then 100 mg/d for 6 weeks, and then either 100 or 140 mg/d for 6 additional weeks.

Abstract: MAIN OUTCOME MEASURES Primary outcome measures were adverse events, plasma and cerebrospinal fluid Abeta levels, vital signs, electrocardiographic data, and laboratory safety test results.

Abstract: Secondary outcome measures included the Alzheimer's Disease Assessment Scale cognitive subscale and the Alzheimer's Disease Cooperative Study Activities of Daily Living Scale.

Abstract: RESULTS Group differences were seen in skin and subcutaneous tissue concerns (P=.05), including 3 possible drug rashes and 3 reports of hair color change in the treatment groups.

Abstract: There were 3 adverse event-related discontinuations, including 1 transient bowel obstruction.

Abstract: The plasma Abeta(40) concentration was reduced by 58.2% for the 100-mg group and 64.6% for the 140-mg group (P<.001).

Abstract: No significant reduction was seen in cerebrospinal fluid Abeta levels.

Abstract: No group differences were seen in cognitive or functional measures.

Abstract: CONCLUSIONS LY450139 was generally well tolerated at doses of up to 140 mg/d for 14 weeks, with several findings indicating the need for close clinical monitoring in future studies.

Abstract: Decreases in plasma Abeta concentrations were consistent with inhibition of gamma-secretase.

Abstract: Trial Registration clinicaltrials.gov Identifier: NCT00244322.


Reduction in skin grafting after the introduction of hydrofiber dressings in partial thickness burns: a comparison between a hydrofiber and silver sulphadiazine.

Abstract: AIM/PURPOSE The aim of this study was to compare clinical outcome of children with scald burns treated with a hydrofiber dressing (Aquacel(®), Convatec Inc.) with the former standard of care with silver sulfadiazine (Flammazine(®); Solvay Pharmaceuticals), considering surgical intervention and length of stay (LOS).

Abstract: METHODS A retrospective study of all consecutive children from zero to four years with primary scald burns up to 10% admitted to the Burn Centre of the Maasstad Hospital Rotterdam between January 1987 and January 2010 were reviewed.

Abstract: For data collection a prospective computerized database was used.

Abstract: For comparison the study period was divided into two periods representing the period before and after the introduction of the hydrofiber dressing (HFD), respectively 1987-1999 (period 1) and 1999-2010 (period 2).

Abstract: RESULTS Over the whole study period 27.3% of 502 patients treated with silver sulfadiazine (Ag-SD) underwent surgery, while before the introduction of HFD 30.5% of 338 Ag-SD treated patients were operated upon.

Abstract: After the introduction of the HFD 20.7% of 164 patients treated with Ag-SD eventually underwent skin grafting, a significant difference with the 11.6% of 302 patients whose wounds were dressed with HFD (p<0.01).

Abstract: CONCLUSIONS Compared to silver sulfadiazine treatment a reduced number of surgical interventions was observed in mixed partial thickness scald burns up to 10% TBSA burned in children aged 0-4 years after the introduction of hydrofiber dressings.

Abstract: The mode of treatment with this wound dressing also limited hospital length of stay.


Induction of the heat-shock response by carbon dioxide in Chironomus thummi.

Abstract: The effects of a set of stress treatments on gene expression of Chironomus thummi salivary gland cells have been analyzed.

Abstract: Among the treatments assayed, only during recovery from carbon dioxide have we observed a response similar to that previously described after heat-shock treatment: induction of the heat-shock puffs and synthesis of the heat-shock polypeptides.

Abstract: In these conditions, puffing and transcription of telomeric regions were observed, which led to the appearance of the temperature-inducible telomeric Balbiani ring T-BR-III.

Abstract: Other treatments failed to induce the heat-shock response, despite promoting real stress conditions to C. thummi larvae or salivary gland cells.